volume 85 issue 3 pages 405-410

Rh(III)‐Catalyzed Redox‐Neutral [4+2] Annulation for Direct Assembly of 3‐Acyl Isoquinolin‐1(2 H )‐ones as Potent Antitumor Agents

Publication typeJournal Article
Publication date2020-03-01
scimago Q2
wos Q2
SJR0.730
CiteScore4.4
Impact factor2.8
ISSN21926506
General Chemistry
Abstract
By virtue of an efficient rhodium(III)-catalyzed redox-neutral C-H activation/ring-opening of a strained ring/[4+2] annulation cascade of N-methoxybenzamides with propargyl cycloalkanols, diverse 3-acyl isoquinolin-1(2H)-ones were directly obtained in good yields and with excellent functional group compatibility. Additionally, their antitumor activities against various human cancer cells including HepG2, A549, MCF-7 and SH-SY5Y were evaluated and the action mechanism of the selected compound was also investigated in vitro. The results revealed that these products possessed a potent efficacy, by inhibiting proliferation and inducing apoptosis in a time-dependent and dose-dependent manner, suggesting that such compounds can serve as promising candidates for anti lung cancer drug discovery.
Found 
Found 

Top-30

Journals

1
2
3
4
European Journal of Organic Chemistry
4 publications, 19.05%
Journal of Organic Chemistry
3 publications, 14.29%
Organic Letters
3 publications, 14.29%
Organic and Biomolecular Chemistry
2 publications, 9.52%
Bulletin of the Chemical Society of Japan
1 publication, 4.76%
Molecular Catalysis
1 publication, 4.76%
Chinese Chemical Letters
1 publication, 4.76%
PLoS ONE
1 publication, 4.76%
Green Chemistry
1 publication, 4.76%
Synthetic Communications
1 publication, 4.76%
ChemCatChem
1 publication, 4.76%
Russian Chemical Reviews
1 publication, 4.76%
Asian Journal of Organic Chemistry
1 publication, 4.76%
1
2
3
4

Publishers

1
2
3
4
5
6
American Chemical Society (ACS)
6 publications, 28.57%
Wiley
6 publications, 28.57%
Royal Society of Chemistry (RSC)
3 publications, 14.29%
Elsevier
2 publications, 9.52%
Oxford University Press
1 publication, 4.76%
Public Library of Science (PLoS)
1 publication, 4.76%
Taylor & Francis
1 publication, 4.76%
Autonomous Non-profit Organization Editorial Board of the journal Uspekhi Khimii
1 publication, 4.76%
1
2
3
4
5
6
  • We do not take into account publications without a DOI.
  • Statistics recalculated weekly.

Are you a researcher?

Create a profile to get free access to personal recommendations for colleagues and new articles.
Metrics
21
Share
Cite this
GOST |
Cite this
GOST Copy
Bian M. et al. Rh(III)‐Catalyzed Redox‐Neutral [4+2] Annulation for Direct Assembly of 3‐Acyl Isoquinolin‐1(2 H )‐ones as Potent Antitumor Agents // ChemPlusChem. 2020. Vol. 85. No. 3. pp. 405-410.
GOST all authors (up to 50) Copy
Bian M., Ma L., Wu M., Wu L., Gao H., Yi W., Zhang C., Zhou Z. Rh(III)‐Catalyzed Redox‐Neutral [4+2] Annulation for Direct Assembly of 3‐Acyl Isoquinolin‐1(2 H )‐ones as Potent Antitumor Agents // ChemPlusChem. 2020. Vol. 85. No. 3. pp. 405-410.
RIS |
Cite this
RIS Copy
TY - JOUR
DO - 10.1002/cplu.201900616
UR - https://doi.org/10.1002/cplu.201900616
TI - Rh(III)‐Catalyzed Redox‐Neutral [4+2] Annulation for Direct Assembly of 3‐Acyl Isoquinolin‐1(2 H )‐ones as Potent Antitumor Agents
T2 - ChemPlusChem
AU - Bian, Mengyao
AU - Ma, Lei
AU - Wu, Min
AU - Wu, Liexin
AU - Gao, Hui
AU - Yi, Wei
AU - Zhang, Chao
AU - Zhou, Zhi
PY - 2020
DA - 2020/03/01
PB - Wiley
SP - 405-410
IS - 3
VL - 85
PMID - 32118370
SN - 2192-6506
ER -
BibTex |
Cite this
BibTex (up to 50 authors) Copy
@article{2020_Bian,
author = {Mengyao Bian and Lei Ma and Min Wu and Liexin Wu and Hui Gao and Wei Yi and Chao Zhang and Zhi Zhou},
title = {Rh(III)‐Catalyzed Redox‐Neutral [4+2] Annulation for Direct Assembly of 3‐Acyl Isoquinolin‐1(2 H )‐ones as Potent Antitumor Agents},
journal = {ChemPlusChem},
year = {2020},
volume = {85},
publisher = {Wiley},
month = {mar},
url = {https://doi.org/10.1002/cplu.201900616},
number = {3},
pages = {405--410},
doi = {10.1002/cplu.201900616}
}
MLA
Cite this
MLA Copy
Bian, Mengyao, et al. “Rh(III)‐Catalyzed Redox‐Neutral [4+2] Annulation for Direct Assembly of 3‐Acyl Isoquinolin‐1(2 H )‐ones as Potent Antitumor Agents.” ChemPlusChem, vol. 85, no. 3, Mar. 2020, pp. 405-410. https://doi.org/10.1002/cplu.201900616.